{
    "2019-11-18": [
        [
            {
                "time": "2018-03-15",
                "original_text": "How Technology Will Disrupt the Way Companies Innovate",
                "features": {
                    "keywords": [
                        "Technology",
                        "Disrupt",
                        "Innovate"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "innovation"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-10",
                "original_text": "UPDATE 1-Novartis switches gears in Shanghai from research to drug development",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Shanghai",
                        "research",
                        "drug development"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-25",
                "original_text": "Novartis Receives FDA Nod for Adakveo in Sickle Cell Disease",
                "features": {
                    "keywords": [
                        "Novartis",
                        "FDA",
                        "Adakveo",
                        "Sickle Cell Disease"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-10",
                "original_text": "Novartis shifts Shanghai's focus from research to early development",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Shanghai",
                        "focus",
                        "early development"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-15",
                "original_text": "Jazz's (JAZZ) Sleep Drug Sunosi Nears Approval in Europe",
                "features": {
                    "keywords": [
                        "Jazz",
                        "Sleep Drug",
                        "Sunosi",
                        "Approval",
                        "Europe"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-02-20",
                "original_text": "Medtech firm Biofourmis doubles valuation with acquisition, Novartis deal",
                "features": {
                    "keywords": [
                        "Biofourmis",
                        "valuation",
                        "acquisition",
                        "Novartis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "medtech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}